Boardroom Alpha
Boardroom Alpha
BOC · Current Report (Form 8-K) · Filed June 15, 2026

Boston Omaha Corp — Current Report (Form 8-K)

Form
8-K
Filed
June 15, 2026
Period
Jun 9, 2026
Ticker
BOC
Accession
0001437749-26-020684
Boardroom Alpha · Filing insights

FIF Utah secures USDA ReConnect loan and grant totaling $11,484,706 each to deploy fiber, guaranteed by Boston Omaha.

About Boston Omaha Corp
Market cap
$406M
1Y TSR
+3.2%
3Y TSR
−6.6%
Board grade
C-
Sector
Communication Services
CEO
Adam K Peterson
Last annual meeting: Aug 21, 2026 · View full Boston Omaha Corp profile →
bomn20260615_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):   June 9, 2026
 
BOSTON OMAHA CORPORATION
(Exact name of registrant as specified in its Charter)
 
Delaware
001-38113
27-0788438
(State or other jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification Number)
 
 
1601 Dodge Street, Suite 3300
Omaha, Nebraska 68102
(Address and telephone number of principal executive offices, including zip code)
 
(857) 256-0079
(Registrant's telephone number, including area code)
 
Not Applicable
(Former name or address, if changed since last report)
 
Securities registered under Section 12(b) of the Exchange Act:
 
Title of Class
Trading Symbol
Name of Exchange on Which Registered
Class A common stock,
$0.001 par value per share
BOC
The New York Stock Exchange
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of Registrant under any of the following provisions (see General Instruction A.2. below):
 
☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act   (17 CFR 240.14d-2(b))
 
☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
 
Emerging growth company  ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
 
 
On June 9, 2026, FIF Utah, LLC ("FIF Utah"), a wholly-owned subsidiary of Boston Omaha Broadband, LLC ("BOB"), received final funding approval from the United States Department of Agriculture of a grant and loan awards under the Rural Utilities Service ReConnect Program.  The loan and the grant are each for $11,484,706, respectively.  The loan will be in the form of long-term debt available as requested by BOB in multiple draw downs over a period not to exceed five years from the date of the award, to deploy fiber to approximately 3,000 locations within FIF Utah's surrounding qualifying markets. The loan portion is a 20 year term loan under the applicable U.S. Treasury rate then in effect at the time of drawdown and subject to customary events of default and remedies.   Interest and principal payments are deferred for a period of three years from the specific drawdown with accrued interest amortized over the remaining term of the loan. Boston Omaha Corporation (the "Company"), as the ultimate parent of FIF Utah, has unconditionally guaranteed the sums due under the loan.
 
The foregoing description of the terms of the Guaranty is not complete and is qualified in its entirety by reference to the text of the Guaranty, a copy of which the Company intends to file as an exhibit to its Quarterly Report on Form 10-Q for the period ended June 30, 2026.
 
 
Item 9.01
Financial Statements And Exhibits
 
(d)
Exhibits. The Exhibit Index set forth below is incorporated herein by reference.
 
EXHIBIT INDEX
 
Exhibit
Number
 
Exhibit Title
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BOSTON OMAHA CORPORATION
(Registrant)
 
       
       
 
By:
/s/ Joshua P. Weisenburger
 
   
Joshua P. Weisenburger,
 
   
Chief Financial Officer
 
 
Date:  June 15, 2026
 
 
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Boston Omaha Corp (BOC)

Reference

Frequently asked questions

When did Boston Omaha Corp file this 8-K?
Boston Omaha Corp (BOC) filed this Current Report (Form 8-K) with the SEC on June 15, 2026. The accession number assigned by EDGAR is 0001437749-26-020684.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
FIF Utah secures USDA ReConnect loan and grant totaling $11,484,706 each to deploy fiber, guaranteed by Boston Omaha. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Boston Omaha Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Boston Omaha Corp has filed under CIK 1494582, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer